<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>ACCEL Lite: Top Takeaways from 2025: HF with Clyde Yancy MD, MSc, MACC</title>
  <description> In this interview, Clyde Yancy MD, MSc, MACC and Alison L. Bailey, MD FACC, discuss the Top Heart Failure Takeaways from 2025 including trials SUMMIT and&amp;amp;nbsp;BaxHTN, the ACC/AHA Blood Pressure Guidelines, and more.&amp;amp;nbsp;   Suggested Materials:&amp;amp;nbsp;   1. Jones DW, Ferdinand KC, Taler SJ, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll&amp;amp;nbsp;Cardiol. 2025;86(18):1567-1678.&amp;amp;nbsp;doi:10.1016/j.jacc.2025.05.007&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;   2. Khan SS, Coresh J,&amp;amp;nbsp;Pencina&amp;amp;nbsp;MJ, et al. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement&amp;amp;nbsp;From&amp;amp;nbsp;the American Heart Association. Circulation. 2023;148(24):1982-2004. doi:10.1161/CIR.0000000000001191&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;   3. Yancy CW. Heart Failure: A Century View, From Failure to Function. Circulation. 2025;151(9):585-588. doi:10.1161/CIRCULATIONAHA.124.072249&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;   4. Packer M, Zile MR, Kramer CM, et al.&amp;amp;nbsp;Tirzepatide&amp;amp;nbsp;for Heart Failure with Preserved Ejection Fraction and Obesity. N&amp;amp;nbsp;Engl&amp;amp;nbsp;J Med. 2025;392(5):427-437. doi:10.1056/NEJMoa2410027&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;   5. Flack JM, Azizi M, Brown JM, et al.&amp;amp;nbsp;Efficacy and Safety of&amp;amp;nbsp;Baxdrostat&amp;amp;nbsp;in Uncontrolled and Resistant Hypertension. N&amp;amp;nbsp;Engl&amp;amp;nbsp;J Med. 2025;393(14):1363-1374. doi:10.1056/NEJMoa2507109&amp;amp;nbsp;  &amp;amp;nbsp;  Subscribe on Apple&amp;amp;nbsp;Podcasts&amp;amp;nbsp;|&amp;amp;nbsp;Subscribe to ACCEL&amp;amp;nbsp;  </description>
  <author_name>ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research</author_name>
  <author_url>http://accelaccorg.libsyn.com/website</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/39236345/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/196095465</thumbnail_url>
</oembed>
